Showing results (101-110 of 188) with videos related to

Sort By:
Pageof 19
Journal of Cachexia, Sarcopenia and Muscle|May 31, 2016
Improvement of skeletal muscle performance in ageing by the metabolic modulator TrimetazidineElisabetta Ferraro, Fabrizio Pin, Stefania Gorini, et al.
Plos One|June 6, 2013
CNF1 increases brain energy level, counteracts neuroinflammatory markers and rescues cognitive deficits in a murine model of Alzheimer's diseaseStefano Loizzo, Roberto Rimondini, Sara Travaglione, et al.
Plos One|October 13, 2015
CNF1 Enhances Brain Energy Content and Counteracts Spontaneous Epileptiform Phenomena in Aged DBA/2J MiceSara Travaglione, Giulia Ballan, Andrea Fortuna, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|December 9, 2010
Copper depletion increases the mitochondrial-associated SOD1 in neuronal cellsMario Arciello, Concetta Rosa Capo, Sara D'Annibale, et al.
Antioxidants & Redox Signaling|April 7, 2009
Oligomerization of mutant SOD1 in mitochondria of motoneuronal cells drives mitochondrial damage and cell toxicityMauro Cozzolino, Maria Grazia Pesaresi, Ilaria Amori, et al.
Journal of Separation Science|October 22, 2019
Enrichments of post-translational modifications in proteomic studiesLuisa Pieroni, Federica Iavarone, Alessandra Olianas, et al.
Cell Death & Disease|May 30, 2021
Inhibition of the mTOR pathway and reprogramming of protein synthesis by MDM4 reduce ovarian cancer metastatic propertiesRossella Lucà, Maria Rita Assenza, Fabio Maiullari, et al.
Cellular and Molecular Neurobiology|May 11, 2026
Fecal miRNome and Proteome Profiling Uncovers Stage-Specific Biomarkers of Alzheimer's Disease in 3×Tg-AD MiceRoberta Vitali, Barbara Tanno, Arianna Casciati, et al.
British Journal of Pharmacology|November 16, 2021
Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1G93A miceSilvia Scaricamazza, Illari Salvatori, Susanna Amadio, et al.
Scientific Reports|June 22, 2019
Innovative mouse model mimicking human-like features of spinal cord injury: efficacy of Docosahexaenoic acid on acute and chronic phasesSara Marinelli, Valentina Vacca, Federica De Angelis, et al.
Pageof 19